Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Suberoylanilide hydroxamic acid

EU orphan designation number: EU/3/04/205
Active ingredient: Suberoylanilide hydroxamic acid
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/06/2004 Centralised Orphan - Designation EMEA/OD/003/04 (2004)2309 of 21/06/2004
16/12/2004 Centralised Orphan - Transfer of orphan designation EMEA/OD/003/04/T/01 (2004)4832 of 15/12/2004
08/02/2013 Centralised Orphan - Removal of orphan designation from Community Register